CD8A and melanoma: Transcriptomic analyses indicated dysregulated mRNA levels of LEF1, TAP1, CD8, and DUSP4 genes in MAPKi-resistant tumors, which correlated with differential methylation at CpG islands, suggesting the critical roles of DNA methylation in transcriptomic reprogramming of melanoma cells to support MAPKi resistance [160].